module 9 warfarin Flashcards
Anticoagulant drug classes
warfarin unfactionated heparin low molecular weight heparin selective factor Xa inhibitors direction thrombin inhibitors
intrinsic and extrinsic pathway meet at
activation of factor X
Vitamin K is needed for synthesis of which coagulation factors
Factors II, VII, IX, X
Protein C and S (natural anticoag)
Warfarin mechanism of action
Vitamin K antagonist:
acts on the carboxylation pathway by inhibiting the regeneration of active vitamin K.
- epoxide reductase enzyme complex
warfarin uses
prevents further extension of formed clots
prevents secondary thromboembolic complications
- no direct effect on established thrombus
- no reversal of ischemic tissue damage
warfarin onset
24 hours
warfarin peak
72-96 hours
warfarin duration of single dose
2-5 days
Warfarin drug effects parallel half life of factors and proteins
Factor II: 60 hrs VII: 4-6 hours IX: 24 hours X: 48 hours Protein C: 8 hours Protein S: 30 hours
Warfarin pharmacokinetics
mixture of R- and S- enantiomers (mirror images)
S: 2-5x anticoag activity
- - metabolized by CYP2C9: dec. warfarin clearance
R: metabolized by CYP pathways: longer half-life
99% albumin bound (low albumin -> inc. free drug)
drugs that enhance warfarin’s anticoag effect
- chloral hydrate: displace warfarin from albumin
- amiodarone, clopidogrel, “-zole”: dec. warfarin metabolisms by inhibiting P450 enzymes
- broad- spectrum abx: dec. gut bacteria-> dec. availability of Vitamin K in GI tract
- anabolic steroids: inhibit synthesis and inc. degradation of coag factors.
Drugs that dec. warfarin’s anticoag effect
- cholestyramine: inhibits warfarin absorption in GI
- barbiturates, carbamazepine, phenytoin, rifampin: accelerate warfarin metabolism by inducing P450 enzymes
- vitamin K (reduced): bypasses warfarin’s inhibition of epoxide reductase
food interactions with warfarin
vitamin K-rich:
- green, leafy veggies
- beef or pork liver
- many fruits, veggies, legumes
Warfarin AE
bleeding
- severe hemorrhage: administer FFP which contains coag factors
- vit. K
Skin necrosis
- microvascular thrombosis via inhibition of C and S
- bridge with heparin
Purple toe syndrome
- breakage of small cholesterol deposits into feet
Osteoporosis
- dec. dietary intake of vit K. / inhibition of vit. K
Warfarin use
completion of anticoag initiated with heparin
prevention of thrombus